Data sourced:
2023.
Page updated:
2025-06-04
In India, Nicotine Replacement Therapy (NRT) is allowed, and it is legal to use, sell, and purchase NRT products from general stores. These products are regulated as medicinal products. The government provides full financial support to cover the cost of NRT, as it is included on the country's essential drugs list. The market size for NRT in India was USD 33.09 million in 2023.
Product promotion
| Year | Value | Reference/Comment |
|---|---|---|
| 2019 | 19.50 million € | 1A |
| 2023 | USD 33.09 million in 2023 | 1B |
References:
- Consumer Health: Euromonitor from trade sources/national statistics. Date Exported: 8/9/2019. (c) Euromonitor International 2019
- Grand View Research. India Nicotine Replacement Therapy Market. Available at: https://www.grandviewresearch.com/industry-analysis/india-nicotine-replacement-therapy-market-report. Accessed: 9 May 2025.
0.30 €
2
2019
References:
- Grand View Research. India Nicotine Replacement Therapy Market. Available at: https://www.grandviewresearch.com/industry-analysis/india-nicotine-replacement-therapy-market-report. Accessed: 9 May 2025.
- Consumer Health: Euromonitor from trade sources/national statistics. Date Exported: 8/9/2019. (c) Euromonitor International 2019
Regulation
References:
- WHO report on the global tobacco epidemic, 2023. Available at: https://cdn.who.int/media/docs/default-source/country-profiles/tobacco/gtcr-2023/tobacco-2023-ind.pdf?sfvrsn=4d7d5aa2_3&download=true. Accessed: 6 May 2025.
Availability
Yes
1
2022
Yes
1
2022
| Year | Value | Reference/Comment |
|---|---|---|
| 2019 | Yes | 1A |
| 2022 | Yes | 1B |
References:
- WHO Report on the Global Tobacco Epidemic 2019. https://www.who.int/tobacco/global_report/en/ (2019).
- WHO report on the global tobacco epidemic, 2023. Available at: https://cdn.who.int/media/docs/default-source/country-profiles/tobacco/gtcr-2023/tobacco-2023-ind.pdf?sfvrsn=4d7d5aa2_3&download=true. Accessed: 6 May 2025.
Yes
2
2019
| Year | Value | Reference/Comment |
|---|---|---|
| 2019 | many general shops without a prescription | 1A |
| 2022 | General stores | 1B |
References:
- WHO Report on the Global Tobacco Epidemic 2019. https://www.who.int/tobacco/global_report/en/ (2019).
- WHO report on the global tobacco epidemic, 2023. Available at: https://cdn.who.int/media/docs/default-source/country-profiles/tobacco/gtcr-2023/tobacco-2023-ind.pdf?sfvrsn=4d7d5aa2_3&download=true. Accessed: 6 May 2025.
References:
- WHO report on the global tobacco epidemic, 2023. Available at: https://cdn.who.int/media/docs/default-source/country-profiles/tobacco/gtcr-2023/tobacco-2023-ind.pdf?sfvrsn=4d7d5aa2_3&download=true. Accessed: 6 May 2025.
- WHO Report on the Global Tobacco Epidemic 2019. https://www.who.int/tobacco/global_report/en/ (2019).
Formal support
Yes NRT is on the country's essential drugs list.
1
A
2022
References:
- WHO report on the global tobacco epidemic, 2023. Available at: https://cdn.who.int/media/docs/default-source/country-profiles/tobacco/gtcr-2023/tobacco-2023-ind.pdf?sfvrsn=4d7d5aa2_3&download=true. Accessed: 6 May 2025.
Comments:
- NRT cost is fully covered by the government.
The GSTHR database is updated regularly by our team.
However, please be aware that the information we provide does not constitute legal advice.
We cannot guarantee that the information is up to date or accurate, as the regulatory status of different product
categories can change at short notice and with little publicity.
If you wish to check the legal status of use or possession of any safer nicotine product in a specific country or region,
you should verify the information independently.
If you have reason to think that the information supplied on the GSTHR is inaccurate, please contact us with details
and any references and we will rectify any errors.